Chongqing-listed vaccine company and China's largest private vaccine distributor, with exclusive distribution rights for Merck's HPV vaccines in China.
No major changes detected in the last 30 days. Monitoring continues.
Language distribution will appear as more signals are collected from diverse sources.
Zhifei controls the distribution of HPV vaccines in China, one of the largest vaccine markets globally. Its transition from distributor to developer of proprietary vaccines is a key trend in Chinese biotech.
Channel context will be available once this company is assigned to a primary channel.
This company operates in one of SigFact's strongest advantage markets, where official updates often surface first in local language.
See recent signals in this marketFollow this company, add it to your watchlist, or explore its signal stream to stay informed.